Q1 2026 earnings call: new KPIs, Vantage acquisition update, land/NOI gains, and $211/share 2030 value framework—read key takeaways.
Now with these positive data in hand, we are focused on our NDA submission to the FDA expected in the third quarter of 2026" (President, CEO & Director Mortimer). "Our base case assumption is a ...
Howard Hughes Holdings Inc. (NYSE: HHH) (the "Company," "HHH," "Howard Hughes," or "we") today reported first quarter 2026 results, highlighting ...
Use our mortgage calculators to help you work out how repayments will affect your household finances, if you could save money ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results